| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |